Ssi Investment Management LLC has filed its 13F form on October 28, 2025 for Q3 2025 where it was disclosed a total value porftolio of $259 Million distributed in 540 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ishares Core S&P 500 ETF with a value of $66.3M, Ishares Iboxx $ Investment Gra with a value of $15.7M, Vanguard Star Fd Vanguard Tota with a value of $14.1M, Ishares Dj Us Tech ETF with a value of $12.9M, and Ishares Inc with a value of $12M.
Examining the 13F form we can see an increase of $11.8M in the current position value, from $247M to 259M .
Ssi Investment Management LLC is based out at Los Angeles, CA
Below you can find more details about Ssi Investment Management LLC portfolio as well as his latest detailed transactions.
Portfolio value
$259 Million
ETFs: $230 Million
Technology: $12.9 Million
Financial Services: $3.83 Million
Communication Services: $3.76 Million
Consumer Cyclical: $3.07 Million
Healthcare: $1.84 Million
Consumer Defensive: $1.57 Million
Industrials: $1.16 Million
Other: $224,000
Stock
Market Cap.
Holding Value (Reported)
# of Shares.
Last Trade
Trade History
-
$0
0.0% of portfolio
-
Q3 2025
Added 41.83%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Added 31.58%
-
$0
0.0% of portfolio
-
Q2 2025
Added 21.3%
-
$0
0.0% of portfolio
-
Q3 2025
New
Brightspring Health Svcs Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.16%
-
$0
0.0% of portfolio
-
Q3 2025
Added 44.89%
-
$0
0.0% of portfolio
-
Q2 2025
Added 46.67%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 48.74%
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 6.17%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 8.94%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 1.0%
-
$0
0.0% of portfolio
-
Q2 2025
Added 19.05%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 91.21%
-
$0
0.0% of portfolio
-
Q3 2025
Added 24.75%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 9.66%
Collegium Pharmaceutical Inc
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 3.75%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced -0.0%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 1.61%
-
$0
0.0% of portfolio
-
Q2 2024
New
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.11%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 56.12%
-
$0
0.0% of portfolio
-
Q3 2025
Added 0.21%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q3 2025
Added 16.87%
Alnylam Pharmaceuticals Inc
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 40.06%
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 1.39%
-
$0
0.0% of portfolio
-
Q3 2025
Added 26.42%
-
$0
0.0% of portfolio
-
Q3 2025
Added 6.69%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 1.99%
-
$0
0.0% of portfolio
-
Q2 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 29.72%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 8.45%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 94.11%
Amphastar Pharmaceuticals In
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 1.34%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 16.35%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 9.61%
-
$0
0.0% of portfolio
-
Q3 2025
New
-
$0
0.0% of portfolio
-
Q2 2025
Reduced 2.77%
-
$0
0.0% of portfolio
-
Q2 2025
Added 19.9%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 3.56%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 31.77%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 19.34%
-
$0
0.0% of portfolio
-
Q3 2025
Added 183.73%
Ares Management Corporation
-
$0
0.0% of portfolio
-
Q3 2025
Reduced 0.04%
Applied Optoelectronics Inc
-
$0
0.0% of portfolio
-
Q2 2025
Added 21.62%
-
$0
0.0% of portfolio
-
Q3 2025
Reduced -0.0%